Olivier Gaide

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


86 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | 2004 | 2003 | 2002 | 2001 |
 
EUSCAP: A Euromelanoma project to investigate skin cancer risk factors in Europe.
Wunderlich K., Suppa M., Lipski J., Deworme V., Wambreuse A., Njimi H., White J., Gaide O., Euromelanoma Working Group, Gandini S. et al. Journal of the European Academy of Dermatology and Venereology. Peer-reviewed.
 
Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.
Kinj R., Gaide O., Jeanneret-Sozzi W., Dafni U., Viguet-Carrin S., Sagittario E., Kypriotou M., Chenal J., Duclos F., Hebeisen M. et al., 2024/03. Clinical and translational radiation oncology, 45 p. 100743. Peer-reviewed.
Nutritional and metabolic characteristics of critically ill patients admitted for severe toxidermia.
Karakus M., Pantet O., Charrière M., Favre D., Gaide O., Berger M.M., 2023/06. Clinical nutrition, 42 (6) pp. 859-868. Peer-reviewed.
Projet SELPHUV : personnaliser la prévention solaire au moyen de la photographie UV
Zimmermann Kathrine, Corre Tanguy, Gaide Olivier, Mueller Christine, Pasche Myriam, Vernez David, Bulliard Jean-Luc, 2023/04/18. (347) 74 [Raisons de santé ; 347], Centre universitaire de médecine générale et santé publique (Unisanté).
 
Mpox (variole du singe) : l’œil du dermatologue [Mpox (Monkeypox): from a dermatologist's point of view]
Marchal O., Sottas C., Pastor D., Toutous Trellu L., Kaya G., Gaide O., 2023/03/29. Revue medicale suisse, 19 (820) pp. 614-617. Peer-reviewed.
 
Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
Ramelyte E., Nägeli M.C., Hunger R., Merat R., Gaide O., Navarini A.A., Cozzio A., Wagner N.B., Maul L.V., Dummer R., 2023. Dermatology, 239 (1) pp. 122-131. Peer-reviewed.
 
Addendum: Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma.
Schaller J., Hajjami H.M., Rusakiewicz S., Ioannidou K., Piazzon N., Miles A., Golshayan D., Gaide O., Hohl D., Speiser D.E. et al., 2022/12/06..
 
Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
Bisig B., Cairoli A., Gaide O., Somja J., Bregnard C., Gaulard P., Xerri L., Lefort K., Missiaglia E., Gilliet M. et al., 2022/10. Virchows Archiv, 481 (4) pp. 653-657. Peer-reviewed.
Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma.
Gaide O., Herrera F.G., Jeanneret Sozzi W., Gonçalves Jorge P., Kinj R., Bailat C., Duclos F., Bochud F., Germond J.F., Gondré M. et al., 2022/09. Radiotherapy and oncology, 174 pp. 87-91. Peer-reviewed.
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]
Coukos A., Daccord C., Lazor R., Blum S., Naveiras O., Unger S., Vionnet J., Gaide O., Koutsokera A., Moschouri E. et al., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1606-1613. Peer-reviewed.
 
Nonmelanocytic Lesions: Actinic Keratosis
Gaide Olivier, Rakosi Adèle, Kuonen François, 2022/07/08. pp. 102-107 dans Atlas of Dermoscopy chap. 6C, CRC Press.
Birth of a Melanoma.
Bogiatzi S., Pagnoni A., Hohl D., Gaide O., 2022/05. Dermatology practical & conceptual, 12 (2) pp. e2022070. Peer-reviewed.
Autoexamen de la peau : de l’œil nu à l’optique du smartphone []
Postel-Vinay N., Baud D., Gaide O., 2021/11/10. Revue medicale suisse, 17 (758) pp. 1948-1951. Peer-reviewed.
Impact de la pandémie de Covid sur la détection des cancers de la peau [Impact of COVID pandemic on the detection of skin cancer]
Triboulet C., Amblas A., Vernez M., Michielin O., Gaide O., 2021/03/31. Revue medicale suisse, 17 (732) pp. 635-639. Peer-reviewed.
La peau vue par différentes méthodes d’imagerie cutanée non invasive [Cutaneous visualization by different non-invasive skin imaging methods]
Gallay C., Ventéjou S., Gaide O., Christen-Zaech S., 2021/03/31. Revue medicale suisse, 17 (732) pp. 624-629. Peer-reviewed.
Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma.
Schaller J., Hajjami H.M., Rusakiewicz S., Ioannidou K., Piazzon N., Miles A., Golshayan D., Gaide O., Hohl D., Speiser D.E. et al., 2021/03/30. Oncotarget, 12 (7) pp. 638-648. Peer-reviewed.
 
Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
Stenz N.A., Stampf S., Arnold A.W., Cozzio A., Dickenmann M., Gaide O., Harms M., Hunger R.E., Laffitte E., Mühlstädt M. et al., 2021. Dermatology, 237 (6) pp. 970-980. Peer-reviewed.
White Globules in Basal Cell Carcinoma: A Dermoscopic Sign With Preoperative Implications.
Pagnoni A., Giroud S., Koulouri A., Hohl D., Gaide O., 2021/01. Dermatology practical & conceptual, 11 (1) pp. e2021103. Peer-reviewed.
Prise en charge par l’ORL des mélanomes cutanés cervico-faciaux [ENT management of head and neck cutaneous melanoma]
Jaballah Vinckenbosch P., Litzistorf Y., Gaide O., Özdemir B.C., Michielin O., Reinhard A., 2020/10/07. Revue medicale suisse, 16 (709) pp. 1853-1859. Peer-reviewed.
Dermatofibrosarcoma protuberans : aspects clinico-pathologiques et prise en charge [Dermatofibrosarcoma protuberans : clinico-pathological aspects and management]
Grizzetti L., Gaide O., Kuonen F., 2020/04/01. Revue medicale suisse, 16 (688) pp. 640-645. Peer-reviewed.
Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
Govender L., Mikulic J., Wyss J.C., Gaide O., Thome M., Golshayan D., 2020. Frontiers in immunology, 11 p. 576651. Peer-reviewed.
 
Treatment of a first patient with FLASH-radiotherapy.
Bourhis J., Sozzi W.J., Jorge P.G., Gaide O., Bailat C., Duclos F., Patin D., Ozsahin M., Bochud F., Germond J.F. et al., 2019/10. Radiotherapy and oncology, 139 pp. 18-22. Peer-reviewed.
 
L’intelligence artificielle et le dermatologue [Artificial intelligence and the skin specialist]
Koulouri A., Kuonen F., Gaide O., 2019/03/27. Revue medicale suisse, 15 (644) pp. 687-691. Peer-reviewed.
 
TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma.
Kuonen F., Surbeck I., Sarin K.Y., Dontenwill M., Rüegg C., Gilliet M., Oro A.E., Gaide O., 2018/11. The Journal of investigative dermatology, 138 (11) pp. 2432-2442. Peer-reviewed.
 
Roger federer pourrait-il jouer en portant un large sombrero ? []
Merat R., Gilliet M., Boehncke W.H., Gaide O., 2018/08/08. Revue medicale suisse, 14 (614) pp. 1422-1423. Peer-reviewed.
 
Shed Skin Cancer, Not Collagen XVII: A New Approach to Targeting Skin Cancer Progression.
Gaide O., Hohl D., 2018/01/03. Molecular therapy, 26 (1) pp. 8-9. Peer-reviewed.
 
Une nouvelle vision de la peau [A new vision of skin]
Rakosi A., Kuonen F., Gaide O., 2017/03/29. Revue medicale suisse, 13 (556) pp. 684-690. Peer-reviewed.
Dermal γδ T Cells Do Not Freely Re-Circulate Out of Skin and Produce IL-17 to Promote Neutrophil Infiltration during Primary Contact Hypersensitivity.
Jiang X., Park C.O., Geddes Sweeney J., Yoo M.J., Gaide O., Kupper T.S., 2017. PloS one, 12 (1) pp. e0169397. Peer-reviewed.
 
Colonisation of basal cell carcinoma by lentigo maligna: a case report, review of the literature, and series follow-up.
Kuonen F., Aschwanden J., Dimaio D.J., Elston D.M., Gilliet M., Hohl D., Gaide O., 2016/10/01. European journal of dermatology : EJD, 26 (5) pp. 465-469. Peer-reviewed.
 
Clues in DeRmoscopy: Dermoscopy of keratoacanthoma.
Kuonen F., Durack A., Gaide O., 2016/08/01. European journal of dermatology : EJD, 26 (4) pp. 419-420. Peer-reviewed.
 
La mémoire dans la peau: implications cliniques [Skin memory: the clinical implications]
Gaide O., 2016/03/30. Revue medicale suisse, 12 (512) pp. 631-634.
 
Clues in DeRmoscopy: dermoscopy of angioma serpiginosum.
Kuonen F., Gaide O., 2016. European journal of dermatology : EJD, 26 (1) p. 118. Peer-reviewed.
 
Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis.
Gaide O., Cattin V., 2016. Dermatology (Basel, Switzerland), 232 Suppl 1 pp. 4-6. Peer-reviewed.
 
Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization.
Gaide O., Clayton H., Girardin M., Kuonen F., 2016. Dermatology (Basel, Switzerland), 232 Suppl 1 pp. 7-8. Peer-reviewed.
 
Nouvelles immunotherapies du mélanome: mécanismes d'action, efficacité et prise en charge des toxicities [New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities]
Moura B., Homicsko K., Berthod G., Cerottini J.P., Guggisberg D., Gaide O., Maillard M.H., Michielin O., 2015/05/20. Revue medicale suisse, 11 (475) pp. 1108,1110-1114.
 
Common clonal origin of central and resident memory T cells following skin immunization
Gaide Olivier, Emerson Ryan O, Jiang Xiaodong, Gulati Nicholas, Nizza Suzanne, Desmarais Cindy, Robins Harlan, Krueger James G, Clark Rachael A, Kupper Thomas S, 2015/05/11. Nature Medicine, 21 (6) pp. 647-653.
Atrophie de Lichtenberg post-vaccinale
Rochat Laurence, Gaide Olivier, Rothuizen Laura E., Genton Blaise, 2015/04/14. Forum Médical Suisse ‒ Swiss Medical Forum, 15 (16) pp. 350-352.
 
Cerebriforms cells in cerebrum: an unusual finding
Sarro R., Gaide O., Letourneau A., Missiaglia E., Bisig B., Hottinger A., Cairoli A., de Leval L., 2015. p. 633 dans 81. Jahrestagung der Schweizerischen Gesellschaft für Pathologie, Der Pathologe.
 
Residents' corner February 2015. Clues in DeRmoscopy: Dermoscopy of amelanotic cutaneous melanoma metastases.
Kuonen F., Gaide O., 2015. European journal of dermatology : EJD, 25 (1) pp. 97-98. Peer-reviewed.
 
Residents'corner August 2015. Clues in DeRmosCopy : Dermoscopy-guided biopsy of lentigo maligna
Kuonen F., Durack A., Gaide O., 2015. European Journal of Dermatology : Ejd, 25 (4) pp. 370-371. Peer-reviewed.
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O., De Gassart A., Coso S., Gestermann N., Di Domizio J., Flatz L., Gaide O., Michielin O., Hwu P., Petrova T.V. et al., 2015. Proceedings of the National Academy of Sciences of the United States of America, 112 (50) pp. 15408-15413.
 
Une lésion cutanée pas si exotique. [Skin ulcers in a returning traveler]
Ebiner J., Gaide O., Pedrazzini B., 2015. Praxis, 104 (9) pp. 467-469. Peer-reviewed.
 
Nouvelle lumière sur la thérapie photodynamique cutanée [New light on skin photodynamic therapy]
Kuonen F., Gaide O., 2014/04/02. Revue medicale suisse, 10 (424) pp. 754,756-759.
 
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient.
Peters S., Bouchaab H., Zimmerman S., Bucher M., Gaide O., Letovanec I., Homicsko K., Michielin O., 2014. Melanoma Research, 24 (5) pp. 496-500.
Generation and characterization of function-blocking anti-ectodysplasin A (EDA) monoclonal antibodies that induce ectodermal dysplasia.
Kowalczyk-Quintas C., Willen L., Dang A.T., Sarrasin H., Tardivel A., Hermes K., Schneider H., Gaide O., Donzé O., Kirby N. et al., 2014. Journal of Biological Chemistry, 289 (7) pp. 4273-4285. Peer-reviewed.
Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
Jaworski M., Marsland B.J., Gehrig J., Held W., Favre S., Luther S.A., Perroud M., Golshayan D., Gaide O., Thome M., 2014. EMBO Journal, 33 (23) pp. 2765-2781.
Swiss clinical practice guidelines on field cancerization of the skin.
Hofbauer G., Anliker M., Boehncke W.H., Brand C., Braun R., Gaide O., Hafner J., Hunger R., Itin P., Kaeuper G. et al., 2014. Swiss medical weekly, 144 pp. w14026. Peer-reviewed.
 
TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis.
Somasekharan S.P., Koc M., Morizot A., Micheau O., Sorensen P.H., Gaide O., Andera L., Martinou J.C., 2013/03. Apoptosis, 18 (3) pp. 324-336. Peer-reviewed.
 
TNF-α and IFN-γ are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis.
Viard-Leveugle I., Gaide O., Jankovic D., Feldmeyer L., Kerl K., Pickard C., Roques S., Friedmann P.S., Contassot E., French L.E., 2013/02. The Journal of investigative dermatology, 133 (2) pp. 489-498. Peer-reviewed.
 
Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin.
Schuepbach-Mallepell S., Philippe V., Brüggen M.C., Watanabe H., Roques S., Baldeschi C., Gaide O., 2013. Journal of Allergy and Clinical Immunology, 132 (6) pp. 1348-1357. Peer-reviewed.
 
Carcinome de Merket: (r)évolution [Merkel cell carcinoma: (r)evolution].
Feldmeyer L., Gaide O., 2013. Revue Médicale Suisse, 9 (380) pp. 723-729.
 
Clinical Implications of CD8+ T-cell infiltration in frequent and rare cancers.
Feldmeyer L., Gaide O., Speiser D.E., 2013. Journal of Investigative Dermatology, 133 (8) pp. 1929-1932.
 
Dermoscopy of acral melanoma: a multicenter study on behalf of the international dermoscopy society.
Braun R.P., Thomas L., Dusza S.W., Gaide O., Menzies S., Dalle S., Blum A., Argenziano G., Zalaudek I., Kopf A. et al., 2013. Dermatology, 227 (4) pp. 373-380. Peer-reviewed.
 
Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memTNF and TNF receptors comparing two memTNF molecules.
Olleros M.L., Vesin D., Bisig R., Santiago-Raber M.L., Schuepbach-Mallepell S., Kollias G., Gaide O., Garcia I., 2012. PloS one, 7 (5) pp. e31469. Peer-reviewed.
Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies.
Kowalczyk C., Dunkel N., Willen L., Casal M.L., Mauldin E.A., Gaide O., Tardivel A., Badic G., Etter A.L., Favre M. et al., 2011. Journal of Biological Chemistry, 286 (35) pp. 30769-30779.
 
PIDD orchestrates translesion DNA synthesis in response to UV irradiation.
Logette E., Schuepbach-Mallepell S., Eckert M.J., Leo X.H., Jaccard B., Manzl C., Tardivel A., Villunger A., Quadroni M., Gaide O. et al., 2011. Cell Death and Differentiation, 18 (6) pp. 1036-1045.
 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites.
Sorg O., Zennegg M., Schmid P., Fedosyuk R., Valikhnovskyi R., Gaide O., Kniazevych V., Saurat J.H., 2009/10/03. Lancet, 374 (9696) pp. 1179-1185. Peer-reviewed.
Biological activity of ectodysplasin A is conditioned by its collagen and heparan sulfate proteoglycan-binding domains.
Swee L.K., Ingold-Salamin K., Tardivel A., Willen L., Gaide O., Favre M., Demotz S., Mikkola M., Schneider P., 2009/10. Journal of Biological Chemistry, 284 (40) pp. 27567-27576. Peer-reviewed.
 
Classifying ectodermal dysplasias: Incorporating the molecular basis and pathways (Workshop II).
Wright J.T., Morris C., Clements S.E., D'Souza R., Gaide O., Mikkola M., Zonana J., 2009/09. American journal of medical genetics. Part A, 149A (9) pp. 2062-2067. Peer-reviewed.
 
Gene therapy and protein therapy of ectodermal dysplasias: a perspective.
Gaide O., 2009/09. American journal of medical genetics. Part A, 149A (9) pp. 2042-2044. Peer-reviewed.
Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X-linked ectodermal dysplasia.
Mauldin E.A., Gaide O., Schneider P., Casal M.L., 2009. American Journal of Medical Genetics. Part A, 149A (9) pp. 2045-2049. Peer-reviewed.
 
Inflammation et auto-immunité: les NOD-like receptors et leur impact en clinique [Inflammation and auto-immunity: an update on the NOD-like receptors and their clinical role]
Gaide O., 2008/04/30. Revue medicale suisse, 4 (155) pp. 1103-1106. Peer-reviewed.
 
Community-acquired methicillin-resistant Staphylococcus aureus infections in two scuba divers returning from the Philippines.
Bochet M., Francois P., Longtin Y., Gaide O., Renzi G., Harbarth S., 2008. Journal of travel medicine, 15 (5) pp. 378-381. Peer-reviewed.
 
Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization.
Watanabe H., Gehrke S., Contassot E., Roques S., Tschopp J., Friedmann P.S., French L.E., Gaide O., 2008. Journal of Immunology, 180 (9) pp. 5826-5832. Peer-reviewed.
 
Insight into the inflammasome and caspase-activating mechanisms.
Gaide O., Hoffman H.M., 2008/01. Expert review of clinical immunology, 4 (1) pp. 61-77. Peer-reviewed.
 
Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression.
Contassot E., Kerl K., Roques S., Shane R., Gaide O., Dupuis M., Rook A.H., French L.E., 2008. Blood, 111 (9) pp. 4780-4787. Peer-reviewed.
 
The proteolytic activity of the paracaspase MALT1 is key in T cell activation
Rebeaud F., Hailfinger S., Posevitz-Fejfar A., Tapernoux M., Moser R., Rueda D., Gaide O., Guzzardi M., Iancu E. M., Rufer N. et al., 2008. Nature Immunology, 9 (3) pp. 272-281. Peer-reviewed.
 
Can automated dermoscopy image analysis instruments provide added benefit for the dermatologist? A study comparing the results of three systems.
Perrinaud A., Gaide O., French L.E., Saurat J.H., Marghoob A.A., Braun R.P., 2007/11. The British journal of dermatology, 157 (5) pp. 926-933. Peer-reviewed.
 
The significance of multiple blue-grey dots (granularity) for the dermoscopic diagnosis of melanoma.
Braun R.P., Gaide O., Oliviero M., Kopf A.W., French L.E., Saurat J.H., Rabinovitz H.S., 2007/11. The British journal of dermatology, 157 (5) pp. 907-913. Peer-reviewed.
 
Death receptors and apoptosis.
Contassot E., Gaide O., French L.E., 2007/10. Dermatologic clinics, 25 (4) pp. 487-501, vii. Peer-reviewed.
 
Exclusively benign dermoscopic pattern in a patient with acral melanoma.
Braun R.P., Gaide O., Skaria A.M., Kopf A.W., Saurat J.H., Marghoob A.A., 2007/09. Archives of dermatology, 143 (9) pp. 1213-5; author reply 1215-6. Peer-reviewed.
 
Surveillance des lésions mélanocytaires [Follow-up of melanoma lesions]
Braun R.P., Gaide O., Le Gal F.A., Saurat J.H., Marghoob A.A., 2007/05/02. Revue medicale suisse, 3 (109) pp. 1119-1123.
 
Diagnosis and management of nail pigmentations.
Braun R.P., Baran R., Le Gal F.A., Dalle S., Ronger S., Pandolfi R., Gaide O., French L.E., Laugier P., Saurat J.H. et al., 2007/05. Journal of the American Academy of Dermatology, 56 (5) pp. 835-847. Peer-reviewed.
 
Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity.
Watanabe H., Gaide O., Pétrilli V., Martinon F., Contassot E., Roques S., Kummer J.A., Tschopp J., French L.E., 2007. Journal of Investigative Dermatology, 127 (8) pp. 1956-1963.
 
Bcl10 controls TCR- and FcgammaR-induced actin polymerization.
Rueda D., Gaide O., Ho L., Lewkowicz E., Niedergang F., Hailfinger S., Rebeaud F., Guzzardi M., Conne B., Thelen M. et al., 2007. Journal of Immunology, 178 (7) pp. 4373-4384.
 
NALP inflammasomes: a central role in innate immunity.
Martinon F., Gaide O., Pétrilli V., Mayor A., Tschopp J., 2007. Seminars in Immunopathology, 29 (3) pp. 213-229.
Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia.
Casal M.L., Lewis J.R., Mauldin E.A., Tardivel A., Ingold K., Favre M., Paradies F., Demotz S., Gaide O., Schneider P., 2007. American Journal of Human Genetics, 81 (5) pp. 1050-1056.
Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.
Bossen C., Ingold K., Tardivel A., Bodmer J.L., Gaide O., Hertig S., Ambrose C., Tschopp J., Schneider P., 2006. Journal of Biological Chemistry, 281 (20) pp. 13964-13971.
Ectodysplasin A1 promotes placodal cell fate during early morphogenesis of ectodermal appendages.
Mustonen T., Ilmonen M., Pummila M., Kangas A.T., Laurikkala J., Jaatinen R., Pispa J., Gaide O., Schneider P., Thesleff I. et al., 2004. Development, 131 (20) pp. 4907-4919.
 
New developments in the history of hypohidrotic ectodermal dysplasia.
Gaide O., 2003. Dermatology, 207 (2) pp. 123-124. Peer-reviewed.
Permanent correction of an inherited ectodermal dysplasia with recombinant EDA.
Gaide O., Schneider P., 2003. Nature Medicine, 9 (5) pp. 614-618.
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex.
Holler N., Tardivel A., Kovacsovics-Bankowski M., Hertig S., Gaide O., Martinon F., Tinel A., Deperthes D., Calderara S., Schulthess T. et al., 2003. Molecular and Cellular Biology, 23 (4) pp. 1428-1440.
 
CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation.
Gaide O., Favier B., Legler D.F., Bonnet D., Brissoni B., Valitutti S., Bron C., Tschopp J., Thome M., 2002. Nature Immunology, 3 (9) pp. 836-843.
 
NF-kappaB signals induce the expression of c-FLIP
Micheau O., Lens S., Gaide O., Alevizopoulos K., Tschopp J., 2001/08. Molecular and Cellular Biology, 21 (16) pp. 5299-305.
 
Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation.
Gaide O., Martinon F., Micheau O., Bonnet D., Thome M., Tschopp J., 2001. FEBS Letters, 496 (2-3) pp. 121-127.
Equine herpesvirus protein E10 induces membrane recruitment and phosphorylation of its cellular homologue, bcl-10.
Thome M., Gaide O., Micheau O., Martinon F., Bonnet D., Gonzalez M., Tschopp J., 2001. Journal of Cell Biology, 152 (5) pp. 1115-1122.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University